Lung volume reduction (LVRO) combined with simultaneous resection of @entity153 ignores the well known principles of functional operability. In case of 6 @entity1 with LVRO and resection of the lung because of a @entity1149 ( @entity1149 ) stage I (4 x), stage II (1 x) and stage IIIa (1 x) located in the emphysematous lung parenchyma lobectomy was done four times and extraanatomical resection twice. Because of a gangrene the resection of middle lobe was necessary in case of one @entity1 . There were no other perioperative complications. 6 months after the operation 5 @entity1 noticed decreased @entity1353 . The survival rate after 2 years was 66 %, after 3 years 34 %. 1 @entity1 is still alive after 56 months. Cause of @entity204 was in every case progress of @entity5 . Due to the principles of oncologic surgery lung resection will be functional tolerated if the @entity5 is located in the area of bullous lung destruction; in singular cases lung resection will improve the cardiorespiratory status at least temporary. In case of extraanatomic or segmental resections there is a low rate of morbidity and lethality but a high incidence of recurrence of @entity189 . The short- and medium- term functional results seem to be encouraging. Limiting factor for carrying out extensive resections is the @entity5 infiltration of @entity1149 . There is no doubt that simultaneous resection will be reserved for a group of highly selected @entity1 .

[Resection of XXXX combined with lung volume reduction].

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity1353 :: ('MESH:D004417', 'Disease') :: ['dyspnea'] @entity5 :: ('MESH:D009369', 'Disease') :: ['cancer', 'tumour'] @entity1149 :: ('MESH:D002289', 'Disease') :: ['NSCLC', 'non-small-cell lung cancer', 'non emphysematous lung parenchyma'] @entity189 :: ('MESH:D002277', 'Disease') :: ['carcinoma'] @entity153 :: ('MESH:D002283', 'Disease') :: ['bronchial carcinoma'] @entity204 :: ('MESH:D003643', 'Disease') :: ['death']
@entity153 :: (MESH:D002283,Disease) :: ['bronchial carcinoma']
